During the fast-paced 'Lightning Round' of Mad Money Thursday night, Jim Cramer answered a caller about Cytosorbents (CTSO) : "You're fine with this one." Let's check out the charts of this maker of a unique blood purification therapy to control deadly inflammation in life-threatening illnesses in the ICU and cardiac surgery.
More from Investing
How Recency Bias and the Pareto Principle impact your trading decisions.
Along with its total subscriber adds, keep an eye on Netflix's regional growth rates, as well as its free cash flow guidance and content spending outlook.
Fundamentals and valuations are secondary to shifting money into certain sectors.
Let's check in again on BAC after its latest earnings.